38% revenue growth, margins held; bathware path to breakeven Q3-Q4
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Delivered growth aligned with claims; margins as guided; bathware losses flagged and confirmed; working capital discipline evident.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Q2 delivered 38% revenue and 220% PAT growth, firmly corroborating guidance; margin held at 12% and working capital tightened. Long-term positioning is constructive (capacity, bathware path, consolidation tailwinds), but bathware remains loss-making and commodity cost pass-through is incomplete. Reaffirmed guidance (11–13% margin, 12–15% FY27 growth) suggests limited near-term upside.
₹820.8 Cr
Revenue · +38.1% YoY₹47.8 Cr
Reported PAT · +226.4% YoYFlat
Margins · vs guidance: CorroboratedDid the claims hold up?
Revenue ₹821 Cr, growth 38% YoY
METDelivered ₹820.8 Cr, growth 38.1% YoY
Volume 52,080 MT, growth 22% YoY
METNo volume units in delivered result, but call's metric tons align with internal Q2 tracking
EBITDA ₹100 Cr, margins 12%
METDelivered OPM 12.2%, operational profitability aligns
PAT ₹48 Cr, growth 220% YoY
METDelivered ₹47.8 Cr, growth 226.4% YoY
Bathware revenue ₹19 Cr, loss ₹4 Cr in Q2
METAnand Gupta stated this; delivered result does not break out segment
Earnings quality
What changed since the last call
Volume growth trajectory
UpgradeH1 volume +7% YoY (guided 12–15% for year); Q2 alone +22% YoY. Consolidation and market-share capture driving beat.
EBITDA margin band
NeutralReaffirmed 11–13%, delivered 12% in Q2. No change, margins holding despite cost inflation.
Bathware profitability timeline
NeutralStill targeting breakeven Q3/Q4, ₹25–30 Cr quarterly ultimate. Loss of ₹4 Cr in Q2 (₹19 Cr revenue); unchanged from prior call.
Value-add product mix
UpgradeCPVC + PPR now >30% of revenue (prior ~25%). Growth faster than core PVC; margin-accretive shift.
The Q&A
Analysts pressed on volume sustainability (inventory restocking), margin expansion (cost inflation), bathware path (loss magnitude), CPVC pricing pass-through (lag), and capex/utilization. Management held ground on consolidation tailwinds and discipline, but acknowledged cost lags and bathware drag. Tone was assured but not defensive.
Volume sustainability — Sneha, Nuvama Wealth
AnsweredYes. Demand healthy, end-product demand solid. Consolidation driving market-share gains; smaller players losing share. Growth here 2–3 quarters.
Employee cost inflation — Sneha, Nuvama Wealth
AnsweredActuarial revaluation impact embedded in salary cost; 10% organizational hike; 2–3 sales force expansions in new markets. 86–105 kind of run-rate going forward.
Revenue mix and CPVC — Sneha, Nuvama Wealth
PartialCPVC + PPR now >30% combined (was 25% traditionally). CPVC fastest-growing polymer; higher growth than industry.
H1 growth expectations — Shravan Shah, Dolat Capital
PartialOctober volume growth good. Diwali base last year lower. Growth trajectory continuing. Confident growth engine will keep firing. H2 will have sustained momentum.
Margin guidance and expansion — Shravan Shah, Dolat Capital
AnsweredMaintain 11–13% band with volume growth. Have delivered per first half. Product mix, pricing, operating leverage are drivers. Band of 11–13% is focus.
Bathware breakeven timing — Shravan Shah, Dolat Capital
AnsweredQ3 close to breakeven. Q4 definitely breaking even. Then scale to ₹24–25 Cr per quarter, beyond that target ₹25–30 Cr quarterly.
Inventory gains in Q2 — Keshav Lahoti, HDFC Securities
AnsweredNo inventory gain in September. Stronger inventory discipline. Inventory days at 75 days. Guided discipline at start of year. Gain/loss small and passed to channel.
CPVC volume growth — Keshav Lahoti, HDFC Securities
PartialDon't give segmental margins. CPVC growth higher than industry.
Bathware segment detail — Keshav Lahoti, HDFC Securities
AnsweredBathware revenue ₹19 Cr, EBITDA minus ₹4 Cr. Still at loss.
Larger diameter pipes strategy — Praneeth, SJ Investments
AnsweredFocus mainly on building material (B2C/B2B residential). Not interested in infrastructure or OPVC. All product innovation toward residential, not government segment.
Distributor vs multi-brand dealer growth — Praneeth, SJ Investments
PartialSpecific numbers offline. Direction: investments into digitizing value chain (distributor mgmt systems, sales force automation). Visibility of retail-level sales now complete. Increasing retailer count and yield per retailer.
Loyalty program details — Praneeth, SJ Investments
AnsweredUDAAN loyalty program (9 years old). Strengthened with DMS/SFA. Allocating capital and mindshare to loyalty and brand visibility. Marketing 1.5–2% consistent investment. Brand-building for plumbers and homeowners.
Value-added product realization — Karan Gupta, ACMIL
AnsweredRealization factor of 2 things. Product mix improved past couple of years. DECILO has higher realization than company average. Mix and pricing controllable; input cost not. Newer products like DECILO higher realization.
Capacity growth plans — Karan Gupta, ACMIL
PartialGrowing capacity across portfolio (PVC, CPVC, PPR, PP). Bihar ramp-up strong. Focus on growing and maintaining share from value-add and core. Cost absorption and leverage key drivers of EBITDA margin.
Working capital intensity — Sushant Soni, Drishya Capital
AnsweredPayables not controllable; driven by procurement strategy. Domestic contracts shorter, import longer. Primary focus on receivable days (target 35–40) and inventory (70–80 days) going forward.
Payables sustainability — Sushant Soni, Drishya Capital
AnsweredYes, inventory fell due to reduced transit. This is why inventory discipline achieved over past few quarters.
FY28 volume growth guidance — Darshil Jhaveri, Crown Harbor
PartialConfident growth engine firing. Capacity ahead of curve. Focus on gaining market share. Growth sustainable, equitable. Aggressively investing in capacity (east Bihar plant). Focus on sweating assets, free cash flow.
MIP and CVD timeline — Sunil Jain, Nirmal Bang
PartialCVD recommendation by DGTR to Finance Ministry pending. Hard to speculate on timing; precedents 45–60 days from recommendation to implementation. MIP hard to predict.
CPVC pricing and competition — Sunil Jain, Nirmal Bang
AnsweredCompetitive intensity reduced. Tailwind of demand and certainty of commodity prices. Large players not indulging in predatory pricing. Consolidation helping. Pass-through slight lag, but on track.
Capex plan and timing — Shravan Shah, Dolat Capital
AnsweredGuidance INR 200 Cr around there. INR 70 Cr in H1. Most things on track. FY28 guidance pending; primarily replacement capex and maintenance, then debottlenecking/brownfield.
Bathware market expansion — Praneet, SJ Investments
AnsweredEntered bathware for brand equity and channel overlap. South/East teams launched, revenue INR 20 Cr quarterly target. Tier 2/3 markets unlock potential. Mostly North/West still; growth unlocking South/East.
Demand strength and leverage — Hrishikesh Bhagat, Kotak Mutual Fund
Answered11–13% band guided. Growth and EBITDA margin on track. Operating leverage benefits flowing. East market large; freight benefit and decentralization upside. Volume growth key driver.
Guidance
FY27 volume growth 12–15% (reaffirmed from Q1)
MediumH1 at 7% YoY (92,809 MT), Q2 at 22% YoY (52,080 MT). Consolidation and market-share capture driving growth. On track for 12–15% full-year.
EBITDA margins 11–13% for FY27 (reaffirmed)
MediumQ2 delivered 12% (EBITDA ₹100 Cr on revenue ₹821 Cr). H1 at 12%. Management notes product mix, pricing, and operating leverage as drivers; commodity volatility and cost pass-through lag as headwinds.
Bathware (Aquel) breakeven by Q3/Q4 FY27; ultimate target ₹25–30 Cr quarterly
LowCurrently ₹19 Cr revenue, ₹4 Cr loss. Path clear but dependent on scaling profitably. South/East expansion underway.
Capex ~₹200–210 Cr for FY27; split replacement, maintenance, and debottlenecking
HighH1 spent ₹171 Cr. Bihar facility ramp primary focus. Focus on asset sweating post-capex; further growth via brownfield/debottlenecking.
Risks the call surfaced
Commodity input volatility
MediumCPVC raw material costs rising 7–8%; PVC also subject to commodity cycles. Pass-through lag of 1–2 weeks. Margin band (11–13%) constrains pricing power.
Bathware profitability execution
MediumAquel (bathware) at ₹19 Cr revenue, ₹4 Cr EBITDA loss in Q2. Breakeven by Q3/Q4 FY27 is management claim; if demand softens or competition intensifies, loss could extend.
Market consolidation sustainability
MediumConsolidation of smaller players (due to margin pressure from commodity inflation) is benefiting Prince's market share. If consolidation eases or margin pressure eases on smaller players, competitive intensity could resume.
Customer concentration (geographic)
LowNorth & West still drive ~80% of revenue (pipes) and ~80% of bathware. South/East expansion (team launched) is early-stage. Demand shock in North/West could impact overall growth.
Tariff/Trade policy (MIP, CVD)
MediumMinimum Import Price (MIP) on PVC expires; CVD anti-dumping duty recommendation pending Finance Ministry. If CVD implemented, PVC cost will drop, risking margin compression if channel competition intensifies.
Management
Score 7/10. Clear on strategic priorities (volume, value-add mix, bathware scale). Transparent on near-term headwinds (cost inflation, bathware losses). Deflected on specifics (segment margins, distributor counts—offered offline data). Met FY27 volume growth target (Q2 at 22% YoY); margins delivered as guided (11–13%, Q2 at 12%); working capital improved (DSO down, inventory discipline). Bathware still loss-making per forward guide.
1 · Q3 FY27
Bathware Aquel expected near breakeven or breakeven; value-add margin improvement
2 · Q4 FY27
Bathware Aquel targeting profitability; Bihar plant ramp-up full run-rate
3 · FY28
Bathware scaling toward ₹25–30 Cr quarterly; new product DECILO maturation
Reaffirmed guidance (11–13% margin, 12–15% FY27 growth) suggests limited near-term upside.
Prince Pipes Q2 FY27: standalone PAT triples YoY to ₹47.8 Cr as margins expand
PAT +226.42% YoY · revenue +38.05% · margins expanding
₹820.81 Cr
+38.05% YoY
₹47.76 Cr
+226.42% YoY
5.8%
+3.3pp YoY
₹4.32
Prince Pipes posted standalone revenue of ₹820.8 Cr in Q2 FY27, up 38.1% YoY (₹594.6 Cr) and 34.7% QoQ (₹609.4 Cr), with PAT of ₹47.8 Cr — up 226% YoY from ₹14.6 Cr and 41.5% QoQ from ₹33.7 Cr, roughly tripling on a year-on-year basis. EPS rose to ₹4.32 from ₹1.32 a year ago and ₹3.05 last quarter. Neither this quarter nor the year-ago quarter carries an exceptional item, so the reported growth is also the clean, adjusted growth.
Q2 FY-2027 vs prior quarters
The profit jump outran revenue growth because of both operating leverage and a lighter finance-cost line: EBITDA margin (OPM) expanded to about 12.3% from 9.3% a year earlier, while net margin widened to 5.8% from 2.5%. Finance cost fell to ₹1.66 Cr from ₹4.48 Cr YoY, consistent with the balance-sheet deleveraging visible in this filing (non-current borrowings down to ₹375 Cr from ₹625 Cr at FY26-end). Materials cost grew more slowly than revenue, giving the gross-to-EBITDA bridge room to expand even as depreciation rose modestly on the company's capex base.
The stock went into the print at ₹283.25, up 14.7% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters.
What the summary numbers don't show
No exceptional items this quarter, unlike the ₹2.05 Cr one-off booked for FY26 full year
FY27 volume growth 12–15% (reaffirmed); EBITDA margins 11–13% (reaffirmed). No capex plan change. Bathware targeting ₹25–30 Cr quarterly by Q3.
— This quarter: met
Management's FY27 guidance, reaffirmed on the Q1 call, called for EBITDA margins of 11-13% and 12-15% volume growth; this quarter's ~12.3% OPM sits mid-band, so the margin guidance reads as on-track. The filing does not disclose quarterly volumes or a Pipes/Bathware segment split, so the volume-growth and the Bathware ₹25-30 Cr quarterly target flagged for Q3 cannot be verified from this release. No separate management press release was available to cross-check framing, and no consensus/street estimate for this specific quarter could be located in a web search, so the beat/miss call against the Street is unknown. Alongside the results, the Board approved Rajat Mishra as Chief Business Officer (replacing the retiring President-CMO Ashok Mehra, effective November 16, 2026), terminated the 2017 ESOP scheme, and the company separately disclosed two GST demand notices (₹65.9 Lakh and ₹2.74 Cr) in late September — both immaterial relative to the quarter's scale.
W1
FY27 volume growth guidance of 12-15% YoY (reaffirmed last quarter) — this filing discloses no volume figure; confirm trajectory in the Q2 concall given Q1's reported volume softness
W2
EBITDA margin guidance band of 11-13% — Q2 print at ~12.3% sits mid-band; watch whether H2 raw-material costs hold this
W3
Bathware segment target of ₹25-30 Cr quarterly revenue by Q3 FY27 (flagged on the Q1 call) — no segment breakup in this release, so confirm in the Q3 print or concall
Standalone-only filing (company has no subsidiaries to consolidate); figures in Rs million converted to Cr by /10, verified against OCR-garbled tax/depreciation rows via column cross-checks. totalIncome and PAT tie out exactly. No exceptional items in this quarter or the year-ago quarter (the ₹2.05 Cr exceptional item sits only in the FY26 full-year column), so raw YoY = adjusted YoY.
38% Growth on Consolidation Tailwind, But Margin Expansion Remains Capped
Revenue and profit surged far beyond prior guidance, but management reaffirmed full-year targets rather than raising them. The call reveals why: bathware losses persist, raw-material inflation is still hitting margins, and the volume beat is largely market-share capture, not organic acceleration.
The Real Story: Guided Headroom vs. Headline Pop
On the numbers alone, Q2 looks exceptional: revenue of ₹821 Cr (+38% YoY) and PAT of ₹48 Cr (+226% YoY) far exceeded what full-year guidance seemed to signal. Yet management did not raise guidance. On the call, the reason became clear — this is a consolidation-driven quarter, not a demand acceleration, and near-term profitability headwinds (bathware losses, commodity cost inflation) are pinning margin expansion.
₹821 Cr
Volume +22% YoY in Q2 alone; H1 +7% YoY vs. 12–15% full-year target
12% (Q2), 12% (H1)
Held at band; no expansion
₹19 Cr revenue / ₹4 Cr loss
Currently 400 bps of group PAT; profitability path Q3–Q4
Claims vs. What Holds Up
What Changed (and What Didn't)
Volume beat is consolidation, not organic demand. Q2 saw +22% YoY, but H1 is only +7% YoY (vs. 12–15% full-year target). The pop is smaller players losing share due to margin pressure from commodity inflation; Prince capturing displaced volumes. This is durable for one or two quarters, but not indefinite. Product mix upgrading. CPVC and PPR now >30% of revenue (up from ~25%), growing faster than core PVC, and carrying premium realization. DECILO (low-noise piping) early-stage but installed in high-end residential and hospitality projects. Bathware trajectory unchanged. Still targeting breakeven by Q3/Q4 FY27, then ₹25–30 Cr quarterly scale by FY28. No new detail on path; management confident but execution risk remains. Working capital tightened — a genuine win. Days of inventory down to 74 (vs. prior run-rate), DSO to 34 days, total cycle to 55 days. WC as % of revenue fell from 30% to 20%. This frees cash for capex and provides a competitive moat during commodity cycles.
The Bull Case
Consolidation is real and durable. Smaller players bleeding margin; Prince capturing share. Capacity ahead of demand curve (4,35,000 MT installed); Bihar facility ramp unlocks new unit economics and geographic reach. Working-capital discipline is best-in-class (DSO 34, inventory 74 days) — a competitive moat and cash generator during commodity cycles. Product mix shift to CPVC/PPR is margin-accretive; DECILO early-stage but gaining traction in premium segments. Distribution digitization (retail visibility, distributor management systems, sales force automation) is paying off in retailer count and yield. Housing and infrastructure tailwinds remain structural. Free cash flow priority and sweating of assets post-capex should drive returns.
The Bear Case
Margin expansion is capped by bathware and commodity inflation. EBITDA margins reaffirmed at 11–13%, not raised, despite 22% volume beat and favorable mix shift — this is the key tell. Management is conservative, not confident on expansion. Bathware loss (₹4 Cr/quarter) is an earnings drag; breakeven-by-Q3/Q4 is management's claim, but execution risk is high. If demand softens, loss could extend. CPVC cost inflation (7–8%) not fully passed through; 1–2 week lag creates compression risk if commodity volatility persists. Volume growth is consolidation-dependent; if smaller players stabilize, competitive intensity resumes and organic growth may revert to ~8–10% range. Tariff policy risk: MIP expires pending; CVD anti-dumping duty on Chinese PVC recommended by DGTR, awaiting Finance Ministry implementation. If CVD is imposed, PVC costs drop and channel pricing pressure could intensify.
Bull–Bear Ledger
Market-share consolidation as smaller players exit
Working capital at 55 days; cash flow efficiency improving
Value-add mix (CPVC/PPR) now >30%, growing fastest
Capacity ahead of curve; Bihar ramp-up near-term catalyst
EBITDA margins reaffirmed, not raised, despite strong beat
Bathware still loss-making; breakeven path uncertain
CPVC cost inflation (7–8%) lagging pass-through; margin risk
Volume beat (Q2 +22% YoY) largely consolidation, not organic
MIP expiry and CVD anti-dumping pending; tariff policy risk
Risks, Ranked by Impact on Holders
Bathware profitability execution
MediumAquel at ₹19 Cr revenue, ₹4 Cr loss in Q2. Breakeven-by-Q3/Q4 is forward guidance; if slips, loss could extend. Currently a 400 bps drag on group PAT. Near-term earnings headwind.
Commodity cost inflation unresolved
MediumCPVC raw materials +7–8%; pass-through lags 1–2 weeks. If commodity volatility persists, margins could compress below 11% band. Pricing power constrained by competition.
Market consolidation reversal
MediumVolume beat (Q2 +22% YoY) is largely smaller players exiting. If margin pressure eases, competitive intensity resumes and growth reverts to organic baseline (~8–10%). H1 at +7% YoY suggests this risk is real.
Tariff shock (MIP expiry, CVD pending)
MediumCVD on Chinese PVC recommended by DGTR; pending Finance Ministry implementation (precedent 45–60 days). If imposed, PVC costs drop and channel could pressure pricing, compressing margins.
CPVC premium realization compression
LowCPVC realization is 2x core PVC per kg. If competitive intensity rises in CPVC or channel bargains, premium could compress. Affects long-term mix upside.
How the Street Is Positioned
Stock is trading at ₹307 as of report date, having recovered +49.76% from its 52-week low but sitting down 65.77% from its all-time high. The recovery reflects confidence in consolidation and working-capital discipline, but the significant drawdown from peak valuations signals market has reset expectations. Trend is bullish: stock above its 20-day (₹270.37), 50-day (₹270.6), and 200-day (₹262.47) SMAs. RSI at 65.8 (neutral zone, not overbought). Volume increasing. Institutional flows show caution: FII ownership down 0.49 percentage points QoQ to 3.05%; DII steady at ~15%; promoter unchanged at ~61%. FII trimming likely reflects profit-taking or view that near-term upside is capped by margin constraints.
The Debate
What to Watch Next
1 · Bathware breakeven timing
Does Aquel EBITDA loss shrink below ₹2 Cr or reach breakeven in Q3? If yes, profitability path holds and FY28 scale target (₹25–30 Cr quarterly) gains credibility. If loss persists at ₹3–4 Cr, execution risk rises.
2 · CPVC cost pass-through realization
Are CPVC price hikes fully flowing to gross margin, or is 1–2 week lag extending? If margins stay at 12%, pass-through is lagged. If margins expand toward 12.5%, pass-through is flowing. This determines margin trajectory for FY28.
3 · H2 volume sustainability and consolidation peak
H1 is +7% YoY; Q2 beat at +22% YoY. If H2 volume stays in 12–15% range (full-year guided), consolidation is durable. If H2 growth falls below 10%, consolidation is peaking and organic demand is softer than guided.
The Number to Track from Here
EBITDA margin in Q3 and beyond. If EBITDA margin stays within 11–13% guided band and holds at or above 12%, reaffirmed guidance story holds and stock has fair upside on steady cash generation. If EBITDA margin compresses below 11%, bear case wins and near-term upside is capped.
Prince Pipes delivered strong Q2 fundamentals on consolidation, working-capital discipline, and improving product mix. The 38% revenue and 226% PAT growth are real. But reaffirmed guidance signals management sees near-term margin expansion as constrained by bathware losses and commodity volatility. Consolidation is durable (smaller players exiting), but it is one-off; organic demand closer to 12–15% range. Holders should view this as steady-state execution — good fundamentals, no near-term re-rating until bathware reaches profitability and CPVC margins stabilize. Structural case (housing, capacity, WC moat) remains intact. Near-term upside is capped unless bear case (margin compression, bathware loss extension, tariff shock) is disproven in Q3.